Shares of Nanalysis Scientific Corp. (CVE:NSCI – Get Free Report) reached a new 52-week low on Tuesday . The company traded as low as C$0.11 and last traded at C$0.11, with a volume of 154925 shares changing hands. The stock had previously closed at C$0.12.
Nanalysis Scientific Stock Performance
The business’s fifty day moving average price is C$0.13 and its 200-day moving average price is C$0.13. The company has a debt-to-equity ratio of 71.72, a current ratio of 1.42 and a quick ratio of 1.10. The stock has a market capitalization of C$16.03 million, a PE ratio of -3.83 and a beta of -0.56.
About Nanalysis Scientific
Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies. It serves pharmaceutical, security, biotech, nutraceutical, chemical, food, materials, medical, and education industries.
Further Reading
- Five stocks we like better than Nanalysis Scientific
- AMD Chips Away at NVIDIA’s AI Throne
- Is the Fed Playing Chess With Rates—Or Just Behind the Curve Again?
- IonQ’s AI Breakthrough Looks Big—But Can It Drive Revenue?
- Broadcom CEO Holds $350B Outlook Strong Amid Calls to Slow Froniter AI Development
Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
